banner2

Getting started
Quinoline-4-Carboxaldehyde

Quinoline-4-Carboxaldehyde - Factory, Suppliers, Manufacturers from China

Quinoline-4-Carboxaldehyde, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

4-Quinolinecarboxaldehyde CAS 4363-93-3 Purity 97.0 (GC)(T) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4-Quinolinecarboxaldehyde CAS 4363-93-3 Purity >97.0% (GC)(T)
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

banner1

Top Selling Products

Related Blog
Reviews

The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) -Shanghai Ruifu Chemical Co., Ltd. will attend with customers.

Shanghai Ruifu Chemical Co., Ltd. will attend the The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) with customers. The 87th China International ...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...

2022.12.16 07:00:42
2022.11.11 19:24:07
2022.09.25 11:12:08
2022.08.30 02:39:56
2022.07.26 22:49:32
2021.12.05 15:33:46

related search